MPA AUC 6–12 was also decreased by ∼30% (from 5.45 ± 3.22 to 3.79 ± 3.18 μg·h/mL) when MMF was co-administrated with TMP-SMX, but this finding did not reach statistical significance ( p = 0.082).
← all excerpts
Gut Microbiota-Mediated Pharmacokinetic Drug-Drug Interactions between Mycophenolic Acid and Trimethoprim-Sulfamethoxazole in Humans.
1
0.0820
0.0820